Showing results (1321-1330 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|September 21, 2004
Comparison of the bioavailability of 250 and 500 mg divalproex sodium extended-release tablets in healthy volunteersSandeep Dutta, Yiming Zhang, Lillian L Lee, et al.Biopharmaceutics & Drug Disposition|August 31, 2004
Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of 3-hydroxydesloratadineAnima Ghosal, Yuan Yuan, Neil Hapangama, et al.Biopharmaceutics & Drug Disposition|August 31, 2004
Pharmacokinetics and dose proportionality of extended-release metformin following administration of 1000, 1500, 2000 and 2500 mg in healthy volunteersEdward Cullen, James Liao, Peter Lukacsko, et al.Biopharmaceutics & Drug Disposition|September 24, 2004
Characterization of early plasma concentrations of midazolam in pigs after administration by an autoinjectorAharon Levy, Moshe Kushnir, Shira Chapman, et al.Biopharmaceutics & Drug Disposition|April 27, 2004
Pharmacokinetic tracer kinetics analysis of changes in erythropoietin receptor population in phlebotomy-induced anemia and bone marrow ablationP Veng-Pedersen, S Chapel, N H Al-Huniti, et al.Biopharmaceutics & Drug Disposition|April 27, 2004
Interaction of dexloxiglumide, a cholecystokinin type-1 receptor antagonist, with human cytochromes P450Michael Hall, Stefano Persiani, Yen-Ling Cheung, et al.Biopharmaceutics & Drug Disposition|April 27, 2004
Interspecies scaling of the monoclonal anti-EGF receptor ior EGF/r3 antibody disposition using allometric paradigm: is it really suitable?Jorge Ducongé, Eduardo Fernández-Sánchez, Daniel AlvarezBiopharmaceutics & Drug Disposition|March 1, 1995
Pharmacokinetics of the novel anticonvulsant HEPP after single intravenous administration of three different doses in dogsL E Gómez, P A LehmannBiopharmaceutics & Drug Disposition|March 1, 1995
The effect of the fat content of food on the pharmacokinetics and pharmacodynamics of SDZ FOX 988, an antidiabetic agent, in the dogD T Lau, G Kalafsky, R L Aun, et al.Biopharmaceutics & Drug Disposition|January 1, 1994
The pharmacokinetics and metabolism of DuP 532, a non-peptide angiotensin II receptor antagonist, in rats and dogsY N Wong, K A Holm, D L Burcham, et al.Pageof 214